(Q83202545)
Statements
A pharmacokinetic-pharmacodynamic model to optimize the phase IIa development program of maraviroc (English)
Maria C Rosario
Bill Poland
John Sullivan
Mike Westby
Elna van der Ryst
scientific article published on 01 June 2006